US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder EP News Bureau Aug 16, 2020 In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
